How Is The Market Feeling About Regeneron Pharmaceuticals?
Portfolio Pulse from Benzinga Insights
Regeneron Pharmaceuticals (NYSE:REGN) has seen a decrease in short interest, with the short percent of float dropping 12.42% since the last report. The company has 1.23 million shares sold short, which is 1.34% of available shares for trading. The current short interest is lower than the peer group average of 5.07%. While a decline in short interest can indicate a more bullish sentiment, it does not necessarily predict a near-term rise in stock price.
December 27, 2023 | 4:45 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Regeneron Pharmaceuticals has experienced a significant decrease in short interest, which may suggest a more bullish sentiment among investors compared to its peers.
A decrease in short interest typically indicates that investors are less bearish on a stock, which could lead to a potential increase in its price in the short term. However, the impact on the stock price is not guaranteed and will depend on broader market conditions and company performance.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100